The firm is a 60M Euro early-stage VC based in London. The firm invests broadly across deep tech including in healthcare and life-sciences. The team is looking for teams that are working on new and innovative technologies, the more unusual the better. The firm invests 1-2M EUR as a Seed+ round (between Seed and Series-A), often helping to bridge the gap between those rounds. The firm invests primarily in Europe, but will consider investing in companies based outside of Europe if they have a strong European connection.
The firm will consider technologies in all areas of healthcare, including therapeutics, diagnostics, drug delivery, tools, digital health and medical devices, instead focusing on the type of technology and how unique it is. They do not invest in single-asset therapeutic companies or repurposed assets. While open to all indications, the firm prefers to invest in underserved indications, such as neuroscience, infectious diseases, solid tumors, ophthalmology, and dermatology.
The firm can lead or follow in their investments. While they may take a board seat, they will only do so if it will be beneficial to the company. The firm invests in strong management teams including founder-driven companies.
If you are interested in more information about this investor and other investors tracked by LSN, please email RESI@lifesciencenation.com.
Next Phase Newsletter 
Leave a Reply